FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980212795> ?p ?o ?g. }

• W2980212795 abstract "Abstract Abstract 3426 Introduction: Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare disorder due to a somatic mutation in the hematopoietic stem cell. The introduction of highly sensitive flow cytometric and aerolysin testing have shown the presence of PNH clones in patients with a variety of other hematological disorders such as aplastic anemia (AA) and myelodysplasic syndrome (MDS). It is hypothesized that patients with these disorders and PNH clones may share an immunologic basis for marrow failure with relative protection of the PNH clone, due to their lack of cell surface expression of immune accessory proteins. This is supported by the literature showing responsiveness in AA and MDS to immunosuppressive treatments. Preliminary results from a recent multicenter trial, EXPLORE, notes that PNH clones can be seen in 70% of AA and 55% of MDS patients, and therefore there may be utility in the general screening of all patients with bone marrow failure (BMF) syndromes. Furthermore, it has been suggested that the presence of PNH cells in MDS is a predictive biomarker that is clinically important for response to immunosuppressive therapy. Methods: Our retrospective cohort study in a tertiary care center used a high sensitivity RBC and FLAER assay to detect PNH clones as small as 0.01%. Of all patients screened with this method, those with bone marrow biopsy and aspirate proven MDS, AA, or other BMF syndromes (defined as unexplained cytopenias) were analysed. Results from PNH assays were compared to other clinical and laboratory parameters such as LDH. Results: Overall, 102 patients were initially screened over a 12 month period at our center. 30 patients were excluded as they did not have biopsy or aspirate proven MDS, AA, or other BMF syndromes. Of the remaining 72 patients, four patients were found to have PNH clones, where 2/51 had MDS (both RCMD, IPSS 0) [3.92%] and 2/4 had AA [50%]. The PNH clone sizes of these four patients were 0.01%, 0.01%, 0.02%, and 1.7%. None of the MDS patients with known recurrent karyotypic abnormalities had PNH clones present. Only one of the four patients had a markedly increased serum LDH level. Conclusions: Our retrospective study indicates much lower incidence of PNH clones in MDS patients or any patients with BMF syndromes when compared to the preliminary data from the EXPLORE trial. There is also significant disagreement in other smaller cohorts in regards to the incidence of PNH in AA and MDS. Screening for PNH clones in patients with bone marrow failure needs further study before adoption of widespread use. Disclosures: Keeney: Alexion Pharmaceuticals Canada Inc.: Consultancy, Membership on an entity's Board of Directors or advisory committees. Wells:Alexion Pharmaceuticals Canada Inc: Honoraria. Sutherland:Alexion Pharmaceuticals Canada Inc.: Consultancy, Membership on an entity's Board of Directors or advisory committees." @default.
• W2980212795 created "2019-10-18" @default.
• W2980212795 creator A5018283449 @default.
• W2980212795 creator A5034014489 @default.
• W2980212795 creator A5043014124 @default.
• W2980212795 creator A5050081321 @default.
• W2980212795 creator A5064109004 @default.
• W2980212795 creator A5082823626 @default.
• W2980212795 creator A5090377657 @default.
• W2980212795 date "2011-11-18" @default.
• W2980212795 modified "2023-10-01" @default.
• W2980212795 title "Screening Patients with Myelodysplastic Syndrome and Aplastic Anemia for Paroxysmal Nocturnal Hemoglobinuria Clones: A Retrospective Study," @default.
• W2980212795 doi "https://doi.org/10.1182/blood.v118.21.3426.3426" @default.
• W2980212795 hasPublicationYear "2011" @default.
• W2980212795 type Work @default.
• W2980212795 sameAs 2980212795 @default.
• W2980212795 citedByCount "1" @default.
• W2980212795 countsByYear W29802127952019 @default.
• W2980212795 crossrefType "journal-article" @default.
• W2980212795 hasAuthorship W2980212795A5018283449 @default.
• W2980212795 hasAuthorship W2980212795A5034014489 @default.
• W2980212795 hasAuthorship W2980212795A5043014124 @default.
• W2980212795 hasAuthorship W2980212795A5050081321 @default.
• W2980212795 hasAuthorship W2980212795A5064109004 @default.
• W2980212795 hasAuthorship W2980212795A5082823626 @default.
• W2980212795 hasAuthorship W2980212795A5090377657 @default.
• W2980212795 hasConcept C109159458 @default.
• W2980212795 hasConcept C126322002 @default.
• W2980212795 hasConcept C167135981 @default.
• W2980212795 hasConcept C203014093 @default.
• W2980212795 hasConcept C2777346216 @default.
• W2980212795 hasConcept C2778248108 @default.
• W2980212795 hasConcept C2778639011 @default.
• W2980212795 hasConcept C2780007613 @default.
• W2980212795 hasConcept C2780525284 @default.
• W2980212795 hasConcept C2780817109 @default.
• W2980212795 hasConcept C2781440808 @default.
• W2980212795 hasConcept C28328180 @default.
• W2980212795 hasConcept C54355233 @default.
• W2980212795 hasConcept C552990157 @default.
• W2980212795 hasConcept C71924100 @default.
• W2980212795 hasConcept C81089528 @default.
• W2980212795 hasConcept C86803240 @default.
• W2980212795 hasConcept C90924648 @default.
• W2980212795 hasConceptScore W2980212795C109159458 @default.
• W2980212795 hasConceptScore W2980212795C126322002 @default.
• W2980212795 hasConceptScore W2980212795C167135981 @default.
• W2980212795 hasConceptScore W2980212795C203014093 @default.
• W2980212795 hasConceptScore W2980212795C2777346216 @default.
• W2980212795 hasConceptScore W2980212795C2778248108 @default.
• W2980212795 hasConceptScore W2980212795C2778639011 @default.
• W2980212795 hasConceptScore W2980212795C2780007613 @default.
• W2980212795 hasConceptScore W2980212795C2780525284 @default.
• W2980212795 hasConceptScore W2980212795C2780817109 @default.
• W2980212795 hasConceptScore W2980212795C2781440808 @default.
• W2980212795 hasConceptScore W2980212795C28328180 @default.
• W2980212795 hasConceptScore W2980212795C54355233 @default.
• W2980212795 hasConceptScore W2980212795C552990157 @default.
• W2980212795 hasConceptScore W2980212795C71924100 @default.
• W2980212795 hasConceptScore W2980212795C81089528 @default.
• W2980212795 hasConceptScore W2980212795C86803240 @default.
• W2980212795 hasConceptScore W2980212795C90924648 @default.
• W2980212795 hasLocation W29802127951 @default.
• W2980212795 hasOpenAccess W2980212795 @default.
• W2980212795 hasPrimaryLocation W29802127951 @default.
• W2980212795 hasRelatedWork W2006860904 @default.
• W2980212795 hasRelatedWork W2017898114 @default.
• W2980212795 hasRelatedWork W2061158771 @default.
• W2980212795 hasRelatedWork W2070033875 @default.
• W2980212795 hasRelatedWork W2229413438 @default.
• W2980212795 hasRelatedWork W2349989072 @default.
• W2980212795 hasRelatedWork W2373929334 @default.
• W2980212795 hasRelatedWork W2535210244 @default.
• W2980212795 hasRelatedWork W2552893887 @default.
• W2980212795 hasRelatedWork W2560612100 @default.
• W2980212795 hasRelatedWork W2898684208 @default.
• W2980212795 hasRelatedWork W2921939649 @default.
• W2980212795 hasRelatedWork W2967212702 @default.
• W2980212795 hasRelatedWork W2980233605 @default.
• W2980212795 hasRelatedWork W2981816066 @default.
• W2980212795 hasRelatedWork W2988688559 @default.
• W2980212795 hasRelatedWork W3034862070 @default.
• W2980212795 hasRelatedWork W3104743470 @default.
• W2980212795 hasRelatedWork W3185628810 @default.
• W2980212795 hasRelatedWork W9662032 @default.
• W2980212795 isParatext "false" @default.
• W2980212795 isRetracted "false" @default.
• W2980212795 magId "2980212795" @default.
• W2980212795 workType "article" @default.